What topics does this cannabis study cover?

This study covers research on: Cancer, THC.

Where was this research published?

Published in Journal of cannabis research on May 28, 2026.

Making CBD more effective against cancer cells

Q: What did this research study find?

Researchers have developed improved versions of *cannabidiol* (CBD), a non-psychoactive compound from cannabis that shows promise against cancer. The main problem they tackled was CBD's poor ability to dissolve in water, which limits how effectively it can be used as medicine. By chemically modifyin

Solubility-improved and antitumor activity of (-)-cannabidiol conjugates.

Journal of cannabis research • May 28, 2026 • Moderately Relevant

🤖

AI Summary

Researchers have developed improved versions of cannabidiol (CBD), a non-psychoactive compound from cannabis that shows promise against cancer. The main problem they tackled was CBD's poor ability to dissolve in water, which limits how effectively it can be used as medicine. By chemically modifying CBD through a process called esterification, scientists created new CBD conjugates that dramatically improved solubility—some versions showed up to 14-fold increases in water solubility compared to regular CBD.

The study tested these modified CBD conjugates against lung cancer cells in laboratory experiments. The results were encouraging: several conjugate versions demonstrated improved cancer-killing ability compared to unmodified CBD, with one derivative (1a) additionally showing the ability to slow cancer cell migration and prevent tumor colony formation. The oligo(ethylene glycol)-based conjugates were particularly effective at improving water solubility, while the L-valine-modified version showed strong improvement across multiple solvents. These findings suggest that the chemical structure of CBD conjugates plays a critical role in both their physical properties and their biological activity.

This research represents an important step toward making CBD-based cancer treatments more practical and effective. By improving solubility, these modified compounds could potentially reach cancer cells more efficiently in the body and provide better therapeutic outcomes. The study demonstrates that strategic chemical modification of CBD can enhance both its pharmaceutical properties and its anti-cancer potential, opening new possibilities for CBD-derived drug development.

📄 Original Abstract

(-)-Cannabidiol (CBD) is a naturally occurring terpenoid belonging to the cannabinoid family, which is isolated from the Cannabis sativa L. plant. It possesses significant therapeutic potential, providing minimal side effects and no psychoactive activity. However, CBD applications are limited by a poor aqueous solubility and low bioavailability. To address these limitations and investigate the impact of structural modification on solubility, we plan in this work the synthesis of a series of CBD conjugates along with the evaluation of their antitumor activity. Conjugates are characterized by Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) techniques, along with the solubility in water, glycerine, n-hexane and isooctane evaluated by High-Performance Liquid Chromatography (HPLC). The antitumoral activity of the CBD conjugates has been tested using cytotoxicity (IC50), cell migration and cell colony formation assays against lung adenocarcinoma cells A549. Specifically, oligo(ethylene glycol)-, alkyl- and L-valine-functionalized CBD derivatives are synthesized via selective esterification of its phenolic groups in good yields. Solubility profiles revealed a marked improvement compared to CBD. Notably, oligo(ethylene glycol) derivatives significantly enhanced solubility in water and glycerine, with 1b exhibiting a 14-fold increase in water solubility. The L-valine bis-conjugated derivative 4 also exhibited substantially improved solubility across all tested solvents, reaching up to a 13-fold increase in glycerine. In contrast, alkyl conjugates 2a,b showed only modest improvements. In addition, the in vitro evaluation against A549 revealed improved cytotoxic activity for 1a, 1b and 4 compared to native CBD, and with 1a additionally displaying antimigratory and colony formation inhibitory effects. Collectively, our results highlight the critical role of conjugate structure in modulating physicochemical and biological properties of CBD and underscore the potential of these CBD conjugates as promising candidates for further pharmacological investigation and development.

Paper Type

📄 Research

Publication

Journal: Journal of cannabis research
Published: May 28, 2026
PMID: 42210316
DOI: 10.1186/s42238-026-00453-5

Authors (9)

Daniel Crespo Dpto. de Química Orgánica, Facultad de Ciencias, Universdad de Málaga, Boulevard Louis Pasteur 31, Málaga, 29071, Spain.
Javier Moreno Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), Granada, 18014, Spain.
Cristina Mesas Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), Granada, 18014, Spain.
Amelia Díaz Dpto. de Química Orgánica, Facultad de Ciencias, Universdad de Málaga, Boulevard Louis Pasteur 31, Málaga, 29071, Spain.
Iván Cheng-Sánchez Dpto. de Química Orgánica, Facultad de Ciencias, Universdad de Málaga, Boulevard Louis Pasteur 31, Málaga, 29071, Spain. cheng@uma.es.
+4 more authors